1.8700
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHAKOUTIS PETER M Officer | Stock Award(Grant) | May 14, 2020 | 23,793 |
| CHEN JASON JING Director | Sale | Dec 7, 2022 | 161,468 |
| DST CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 6, 2023 | 3,756,550 |
| DU ZIAOYU Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 29, 2018 | 750,000 |
| GREEN DAVID R Chief Executive Officer | Purchase | May 12, 2022 | 175,329 |
| HE JUNLI Chief Executive Officer | Purchase | Dec 24, 2024 | 262,000 |
| MCNAUGHTON THOMAS W JR. Chief Financial Officer | Purchase | Jun 15, 2018 | 13,734 |
| SHMERLING JAMES E Director | Purchase | Aug 21, 2023 | 23,756 |
| YOUNG JEFFREY E Director | Conversion of Exercise of derivative security | Sep 30, 2019 | 25,000 |
| YU HONG President | Sale | Dec 7, 2022 | -- |
Related Tickers
1541.HK IMMUNEONCO-B
5.050
0.00%
WXXWY WuXi Biologics (Cayman) Inc.
5.17
0.00%
TIL Instil Bio, Inc.
15.46
+1.01%
ANRO Alto Neuroscience, Inc.
2.2600
+0.44%
9926.HK Akeso, Inc.
82.950
-0.90%
LPCN Lipocine Inc.
3.0000
0.00%
IMUX Immunic, Inc.
0.9800
+3.98%
ANVS Annovis Bio, Inc.
1.2200
-3.17%
BSEM BioStem Technologies, Inc.
12.17
-4.40%
RCKT Rocket Pharmaceuticals, Inc.
6.33
+2.93%